Dr. Stephen M. Strakowski MD
Psychiatrist | PsychiatryUniversity Of Cincinnati College Of Medicine 231 Albert Sabin Way Cincinnati OH, 45267
Dr. Stephen Strakowski is a psychiatrist practicing in Cincinnati, OH. Dr. Strakowski is a medical doctor specializing in the care of mental health patients. As a psychiatrist, Dr. Strakowski diagnoses and treats mental illnesses. Dr. Strakowski may treat patients through a variety of methods including medications, psychotherapy or talk therapy, psychosocial interventions and more, depending on each individual case. Different medications that a psychiatrist might prescribe include antidepressants, antipsychotic mediations, mood stabilizers, stimulants, sedatives and hypnotics. Dr. Strakowski treats conditions like depression, anxiety, OCD, eating disorders, bipolar disorders, personality disorders, insomnia, ADD and other mental illnesses.
Education and Training
Vanderbilt Univ Sch of Med, Nashville Tn 1988
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
- Schizoaffective disorder: role of atypical antipsychotics.
- An overview of the treatment of schizoaffective disorder.
- Olanzapine-induced tardive dystonia.
- Directed forgetting deficits in patients with temporal lobe epilepsy: an information processing perspective.
- Traumatic brain injury in individuals convicted of sexual offenses with and
- The efficacy of atypical antipsychotics in the treatment of depressive symptoms,
- Twelve-month outcome in bipolar patients with and without personality disorders.
- Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
- Placebo effect in randomized, controlled studies of acute bipolar mania and depression.
- Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder.
- Racial differences in treatment of adolescents with bipolar disorder.
- Case report: treatment of catatonia in an adolescent male.
- Quetiapine for treatment-resistant mania.
- Treatment of schizoaffective disorder with divalproex sodium.
- fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder.
- 15-year outcome of treated bipolar disorder.
- Effects of race on psychiatric diagnosis of hospitalized adolescents: a
- Prior stimulant treatment in adolescents with bipolar disorder: association with
- Persistent attentional dysfunction in remitted bipolar disorder.
- A pilot study of rapid lithium administration in the treatment of acute mania.
- Symptom dimensions in acutely ill patients with affective, schizoaffective, and schizophrenic disorders.
- Frequency and severity of religious delusions in Christian patients with psychosis.
- A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
- Verbal fluency in mania: relationship to number of manic episodes.
- D3 dopamine receptor, behavioral sensitization, and psychosis.
- Behavioral sensitization in humans.
- Reaction time measures of sustained attention differentiate bipolar disorder from schizophrenia.
- Age-related changes in regional activation during working memory in young adults: an fMRI study.
- Changes in neuronal activation with increasing attention demand in healthy volunteers: an fMRI study.
- Neuroanatomic characterization of schizoaffective disorder using MRI: a pilot study.
- Academic and cognitive abilities in children of parents with bipolar disorder: a test of the nonverbal learning disability model.
- Regional prefrontal gray and white matter abnormalities in bipolar disorder.
- Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder.
- A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
- Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy.
- Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review.
- Boundaries of schizophrenia.
- Facial affect recognition deficits in bipolar disorder.
- Parental reports of executive dysfunction in adolescents with bipolar disorder.
- Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features.
- Verbal memory in mania: effects of clinical state and task requirements.
- A reevaluation of sustained attention performance in temporal lobe epilepsy.
- Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
- Ethnicity and first-rank symptoms in patients with psychosis.
- Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder.
- Selective attention in schizoaffective disorder: pilot data.
- Sex, ethnicity, and antipsychotic medication use in patients with psychosis.
- Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study.
- Divalproex for the treatment of aggression associated with adolescent mania.
- Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.
- Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task.
- Parametric neurocognitive task design: a pilot study of sustained attention in adolescents with bipolar disorder.
- The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.
- Processing efficiency and sustained attention in bipolar disorder.
- Factors associated with medication adherence in African American and white patients with bipolar disorder.
- Changes in gray matter volume in patients with bipolar disorder.
- Working memory and inhibitory control among manic and euthymic patients with bipolar disorder.
- MRI analysis of cerebellar vermal abnormalities in bipolar disorder.
- Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
- Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders.
- Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder.
- Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task.
- Family environment in families with versus families without parental bipolar disorder: a preliminary comparison study.
- Stability of estimated IQ across mood state in patients with bipolar disorder.
- Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalization.
- Ethnic differences in symptom presentation of youths with bipolar disorder.
- Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study.
- Processing efficiency and directed forgetting in bipolar disorder.
- Open-label lithium for the treatment of adolescents with bipolar depression.
- A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.
- The influence of religious affiliation on time to first treatment and hospitalization.
- Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
- Bipolar disorder and advances in neuroimaging: a progressive match.
- The neurophysiology of childhood and adolescent bipolar disorder.
- Brain network dysfunction in bipolar disorder.
- Fast spectroscopic imaging using online optimal sparse k-space acquisition and projections onto convex sets reconstruction.
- Anterior cingulate subregion volumes and executive function in bipolar disorder.
- Obstetrical complications in children at high risk for bipolar disorder.
- Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.
- Cortical reorganization following modified constraint-induced movement therapy: a study of 4 patients with chronic stroke.
- Concurrent tracking of alcohol use and bipolar disorder symptoms.
- Voxel-based study of structural changes in first-episode patients with bipolar disorder.
- Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.
- Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.
- Child behavior checklist profiles of children and adolescents with and at high risk for developing bipolar disorder.
- The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
- Dopamine and serotonin receptor binding and antipsychotic efficacy.
- Psychopathology in children of bipolar parents.
- Health-related quality of life in adolescents with bipolar I disorder.
- Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
- Twelve-month outcome of adolescents with bipolar disorder following first
- A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
- Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder.
- Evidence of anterior temporal atrophy in college-level soccer players.
- Approaching the challenge of bipolar depression: results from STEP-BD.
- A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
- The prevalence and significance of substance use disorders in bipolar type I and II disorder.
- Neuroanatomical characterization of child offspring of bipolar parents.
- Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium.
- Wisconsin Card Sorting Test performance in bipolar disorder: effects of mood state and early course.
- Inhibition and attention in adolescents with nonmanic mood disorders and a high risk for developing mania.
- Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
- Episode sequence in bipolar disorder and response to lithium treatment.
- Cerebellar ataxia in youths at risk for bipolar disorder.
- Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use.
- Temperament in child offspring of parents with bipolar disorder.
- Brain structures involved in bipolar disorder: findings from structural and functional imaging.
- Morphometric magnetic resonance imaging in psychiatry.
- A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
- Differential patterns of brain activation over time in adolescents with and without attention deficit hyperactivity disorder (ADHD) during performance of a sustained attention task.
- The functional neuroanatomy of bipolar disorder.
- The role of complex emotions in inconsistent diagnoses of schizophrenia.
- Functional MRI of sustained attention in bipolar mania.
- Preliminary evidence for increased frontosubcortical activation on a motor impulsivity task in mixed episode bipolar disorder.
- Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder.
- Broadening the diagnosis of bipolar disorder: benefits vs. risks.
- Behavior regulation and mood predict social functioning among healthy young adults.
- Influence of patient race and ethnicity on clinical assessment in patients with affective disorders.
- Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder.
- A longitudinal functional connectivity analysis of the amygdala in bipolar I disorder across mood states.
- Selective role for striatal and prefrontal regions in processing first trial feedback during single-trial associative learning.
- 4-T 7Li 3D MR spectroscopy imaging in the brains of bipolar disorder subjects.
- Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.
- Bioenergetics for depression: something different for depression.
- The complexities of depression.
- Cigarette smoking and impulsivity in bipolar disorder.
- 1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer.
- Unplanned pregnancies in adolescents with bipolar disorder.
- A systematic review of the evidence for the treatment of acute depression in bipolar I disorder.
- Pharmacotherapies for treating opioid use disorder.
- Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study.
- Mood management and nicotine patch for smoking cessation in adults with bipolar disorder.
- Bipolar I disorder and major depressive disorder show similar brain activation during depression.
- Impulsivity predicts time to reach euthymia in adults with bipolar disorder.
- Age-dependent decreases of high energy phosphates in cerebral gray matter of patients with bipolar I disorder: a preliminary phosphorus-31 magnetic resonance spectroscopic imaging study.
- Impact of functional magnetic resonance imaging (fMRI) scanner noise on affective state and attentional performance.
- First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.
- Tissue-dependent cerebral energy metabolism in adolescents with bipolar disorder.
- MRI Evidence of Neuropathic Changes in Former College Football Players.
- Minding the Gap: Factors Associated With Primary Care Coordination of Adults in 11 Countries.
- Prediction of lithium response in first-episode mania using the LITHium
- Paternal hydrocarbon exposure in Prader-Willi syndrome.
- Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder.
- Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
- The co-occurrence of mania with medical and other psychiatric disorders.
- Outcome and comorbidity in first- compared with multiple-episode mania.
- Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
- Pharmacologic treatment of schizoaffective disorder.
- Diagnostic and treatment implications of psychiatric comorbidity with migraine.
- Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
- Compulsive buying: a report of 20 cases.
- Diagnostic validity of schizophreniform disorder.
- A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
- Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder.
- Mania, psychosis, and antipsychotics.
- Factors associated with pharmacologic noncompliance in patients with mania.
- New developments in the pharmacologic treatment of schizoaffective disorder.
- Are impulse-control disorders related to bipolar disorder?
- Differences in thyroid function studies in acutely manic adolescents with and without attention deficity hyperactivity disorder (ADHD).
- Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia.
- Anticonvulsants and antipsychotics in the treatment of bipolar disorder.
- Differences in cerebral activation during smooth pursuit and saccadic eye movements using positron-emission tomography.
- Enhanced behavioral response to repeated d-amphetamine and personality traits in humans.
- Mc Lean Hosp, Psychiatry
- McLean Hospital
- Harvard University School of Medicine - Boston, MA
Dr. Stephen M. Strakowski MD's Practice location
Cincinnati, OH 45267Get Direction
AUSTIN, TX 78712Get Direction
Cincinnati, OH 45267Get Direction
Dr. Stephen M. Strakowski MD's reviewsWrite Review
Patient Experience with Dr. Strakowski
- Pristiq vs. Effexor
Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...
- Nymphomania: Causes, Symptoms, Treatment, and Diagnosis
Nymphomania is a mental disorder. The person shows characteristic compulsive sexual behavior. Compulsive means unwanted actions and rituals. The person repeatedly engages in it without getting any pleasure out of it, or the person is unable to control the behaviors. A person with nymphomania acts...
- What Is Akathisia: Causes, Symptoms, and Treatment
What is akathisia?Akathisia is a feeling of anxiety or restlessness. Its symptoms tend to overlap with the symptoms of other physical and psychological disorders. The diagnosis depends on a very subjective feeling of restlessness. Hence, recognizing akathisia can be somewhat tricky. Movement...
- What Is Tachypnea?
Introduction Tachypnea is a medical term, which means rapid and shallow breathing. This condition is often confused with hyperventilation, which is another type of abnormal breathing that is characterized by rapid but deep breathing. Both conditions are caused by carbon dioxide buildup in the...
- The Top 10 Health Threats For Men
Here is a list of the top 10 dangerous diseases men can face in their lifetime. Don't be alarmed; many of these diseases are preventable and treatable. 1. Heart attack and cardiac arrestHeart attacks are caused by a blockage of any arteries that supply blood to the heart. Arteries can get clogged...
- What Is a Psychosomatic Disorder?
What is a psychosomatic disorder?It is a disorder wherein physical symptoms develop due to mental factors. The term "psyche" refers to the word "mind" and "somatic" means the observed physical signs and symptoms of the disease. Every disease has physical and mental components, so most diseases are...
- Dr. Paul E. Keck MD4075 Old Western Row Road Mason Ohio 45040
- Mohamed Aziz6402 Thornberry Court Mason Ohio 45040
- Dr. Sarah E. Carreira M.D.6352 Parry Lane Cincinnati Ohio 45213
- Dr. Giuliana Centurion D.O.1549 Reid Ave Cincinnati OH 45224
- Dr. James P Cho M.D.1101 Summit Rd Cincinnati OH 45237
- Dr. Rodney E. Vivian M.D.8000 5 Mile Rd Cincinnati OH 45230